BE867423A - Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques - Google Patents

Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques

Info

Publication number
BE867423A
BE867423A BE187994A BE187994A BE867423A BE 867423 A BE867423 A BE 867423A BE 187994 A BE187994 A BE 187994A BE 187994 A BE187994 A BE 187994A BE 867423 A BE867423 A BE 867423A
Authority
BE
Belgium
Prior art keywords
treatment
therapeutic composition
composition based
aliphatic ketone
peptic ulcers
Prior art date
Application number
BE187994A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of BE867423A publication Critical patent/BE867423A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE187994A 1977-05-26 1978-05-24 Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques BE867423A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6042777A JPS53145922A (en) 1977-05-26 1977-05-26 Remedy for peptic ulcer containing prenyl ketone compound

Publications (1)

Publication Number Publication Date
BE867423A true BE867423A (fr) 1978-09-18

Family

ID=13141907

Family Applications (1)

Application Number Title Priority Date Filing Date
BE187994A BE867423A (fr) 1977-05-26 1978-05-24 Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques

Country Status (8)

Country Link
US (1) US4169157A (fr)
JP (1) JPS53145922A (fr)
BE (1) BE867423A (fr)
DE (1) DE2822727A1 (fr)
FR (1) FR2391723A1 (fr)
GB (1) GB1602566A (fr)
PH (1) PH13999A (fr)
SE (1) SE7805990L (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742643A (en) * 1980-08-29 1982-03-10 Eisai Co Ltd 6,10,14,18-tetramethyl-5,9,13,17-nonadecatetraene-2-ol
JPS5772933A (en) * 1980-10-23 1982-05-07 Agency Of Ind Science & Technol Polyprenylketone derivative and its preparatio
GB2122610B (en) * 1982-05-28 1987-04-01 Eisai Co Ltd A polyprenyl compound and a pharmaceutical composition containing a polyprenyl compound
JPH07103019B2 (ja) * 1985-07-04 1995-11-08 エーザイ株式会社 胃炎治療・予防剤
JP2708126B2 (ja) * 1987-08-25 1998-02-04 日清製粉株式会社 イソプレノイド誘導体とそれを含有する抗潰瘍剤
JP4632480B2 (ja) * 2000-05-16 2011-02-16 レドックス・バイオサイエンス株式会社 チオレドキシン誘導物質
US20040249219A1 (en) * 2000-07-05 2004-12-09 Saucy Gabriel G. Method of making teprenone
JP2004534050A (ja) * 2001-06-07 2004-11-11 エーザイ株式会社 細胞ストレスに関連する疾病及び状態を予防及び治療する方法
US6846845B2 (en) 2002-01-09 2005-01-25 Naohiko Takahashi Heat shock protein inducer
JPWO2004047822A1 (ja) * 2002-11-22 2006-03-23 エーザイ株式会社 テプレノンを充填したヒドロキシプロピルメチルセルロースカプセル製剤
KR101295439B1 (ko) 2004-01-16 2013-08-09 칼 짜이스 에스엠티 게엠베하 편광변조 광학소자
US8355927B2 (en) 2010-11-05 2013-01-15 Genomind, Llc Neuropsychiatric test reports
US20110237537A1 (en) * 2009-05-29 2011-09-29 Lombard Jay L Methods for assessment and treatment of mood disorders via single nucleotide polymorphisms analysis
EP2423177A1 (fr) 2010-08-25 2012-02-29 Nyken Holding B.V. Analogues du géranylgéranylacétone (GGA)
CA2850716A1 (fr) * 2011-10-04 2013-04-11 Coyote Pharmaceuticals, Inc. Derives de geranylgeranylacetone
JP2015514686A (ja) 2012-02-29 2015-05-21 コヨーテ・ファーマシューティカルズ・インコーポレイテッドＣｏｙｏｔｅ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Ｇｇａ及びそのｇｇａ誘導体組成物並びにこれらを含む麻痺状態を含めた神経変性疾患を治療する方法
WO2013157926A1 (fr) 2012-04-19 2013-10-24 Nyken Holding B.V. Analogues de géranyl géranyl acétone et applications associées
US9119808B1 (en) 2012-10-08 2015-09-01 Coyote Pharmaceuticals, Inc. Treating neurodegenerative diseases with GGA or a derivative thereof
CN105732340A (zh) * 2016-04-15 2016-07-06 四川墨凯科技有限公司 一种替普瑞酮的合成工艺
CN105859524A (zh) * 2016-04-15 2016-08-17 四川墨凯科技有限公司 一种反式，反式-金合欢醇的合成方法
CA3060388A1 (fr) 2016-04-21 2017-10-26 Stichting Vumc Moyen et procedes de traitement d'une dysfonction diastolique chez un sujet
CN107501070B (zh) * 2016-06-14 2022-03-11 成都国为生物医药有限公司 一种替普瑞酮的精制方法及其中间体
CN109574821B (zh) * 2018-11-06 2021-12-28 黄冈鲁班药业股份有限公司 一种替普瑞酮合成的中间体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429970A (en) * 1961-02-02 1969-02-25 Hoffmann La Roche Method of hindering the metamorphosis and reproduction of arthropodes
GB938712A (en) * 1961-05-24 1963-10-02 Angeli Inst Spa Farnesyl acetic esters
FR1363573A (fr) * 1963-06-27 1964-06-12 Hoffmann La Roche Procédé pour la préparation de cétones oléfiniques
US3824319A (en) * 1971-01-07 1974-07-16 Us Agriculture Arthropod maturation inhibition employing certain epoxy compounds
US3729486A (en) * 1971-02-01 1973-04-24 Zoecon Corp Epithio di-unsaturated aliphatic ketones and aldehydes
US3978230A (en) * 1974-01-24 1976-08-31 The United States Of America As Represented By The Secretary Of Agriculture Arthropod maturation inhibitors

Also Published As

Publication number Publication date
PH13999A (en) 1980-11-28
GB1602566A (en) 1981-11-11
FR2391723A1 (fr) 1978-12-22
DE2822727C2 (fr) 1987-01-29
JPS53145922A (en) 1978-12-19
US4169157A (en) 1979-09-25
JPS6344726B2 (fr) 1988-09-06
SE7805990L (sv) 1978-11-27
FR2391723B1 (fr) 1984-11-02
DE2822727A1 (de) 1978-11-30

Similar Documents

Publication Publication Date Title
BE867423A (fr) Composition therapeutique a base de cetone aliphatique pour le traitement des ulceres peptiques
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
BE870055A (fr) Compositions et procede pour le traitement des calculs renaux
BE875945A (fr) Derives anthraquinoniques pour le traitement des arthrites
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
ZA767653B (en) Treatment of waste
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
BE876157Q (fr) Medicament pour le traitement de l'acne
BE869152A (fr) Dispositif pour le traitement de la surface de corps presentant des contours irreguliers
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
FR2347311A1 (fr) Traitement d'effluents
JPS5367290A (en) Hydraulic cement for dental treatment
BE841018A (fr) Conteneur de traitement
BE884537A (fr) Traitement des effluants de carbonylation
FR2341315A1 (fr) Medicaments pour le traitement des neuropathies
BE871843A (fr) Traitement des dechets
BE862274A (fr) Acides carboxyphosphoriques utilisables pour le traitement d'eaux
BE844351A (fr) Procede de traitement d'un effluent
BE871753A (fr) Nouvelle utilisation therapeutique de l'acetyl-1-carnitine pour le traitement des affections cardiaques
BE858692A (fr) Composition pour le traitement de l'acne
BE856957A (fr) Electrode pour traitement d'ionophorese
FR2311553A1 (fr) Medicament pour le traitement de la schizophrenie
BE842389A (fr) Composition pharmaceutique pour le traitement de l'hyperuricemie
FR2315931A1 (fr) Traitement de la mammite bovine
FR2321934A1 (fr) Procede et dispositif pour le traitement a la vapeur d'agglomeres

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: EISAI CO. LTD

Effective date: 19980524